Cargando…

Making Visible HTLV Infection in a Non-endemic Area of Argentina

In Argentina, the human T-cell lymphotropic virus type 1 (HTLV-1) infection has been documented mainly among blood banks with a prevalence of ~0.02–0.046% for Buenos Aires city, 0.8% for the northeast, and 1% for the northwest; both areas are considered endemic for HTLV-2 and 1, respectively. Polici...

Descripción completa

Detalles Bibliográficos
Autores principales: Simioli, Federico R., Bouzas, Maria B., Mijalovsky, Dana, Pineda, Maria V., Mammana, Lilia, Mangano, Andrea, Orduna, Tomas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307993/
https://www.ncbi.nlm.nih.gov/pubmed/35879924
http://dx.doi.org/10.3389/fmed.2022.892159
_version_ 1784752888555241472
author Simioli, Federico R.
Bouzas, Maria B.
Mijalovsky, Dana
Pineda, Maria V.
Mammana, Lilia
Mangano, Andrea
Orduna, Tomas A.
author_facet Simioli, Federico R.
Bouzas, Maria B.
Mijalovsky, Dana
Pineda, Maria V.
Mammana, Lilia
Mangano, Andrea
Orduna, Tomas A.
author_sort Simioli, Federico R.
collection PubMed
description In Argentina, the human T-cell lymphotropic virus type 1 (HTLV-1) infection has been documented mainly among blood banks with a prevalence of ~0.02–0.046% for Buenos Aires city, 0.8% for the northeast, and 1% for the northwest; both areas are considered endemic for HTLV-2 and 1, respectively. Policies and specific guidelines for testing blood donors for HTLV are included since 2005. Screening for antibodies is performed at blood banks and confirmatory testing is performed at reference laboratories. There are no specific recommendations for the assistance of communities and individuals affected, nor referral to specialized clinics on the HTLV infection. In 2016, as a strategy of intervention, we opened a specialized clinical attendance in a referral infectious diseases public hospital for the comprehensive approach to patients with HTLV, offering follow-up and counseling for patients and their families for the early diagnosis of HTLV-1/2 and related diseases. During the study, 124 patients with presumptive HTLV positive diagnosis from blood bank, symptomatic patients (SPs), relatives, and descendants visited the unit. A total of 46 patients were HTLV positive (38 HTLV-1 and 8 HTLV-2). There were nine SPs (2 adult T-cell leukemia/lymphoma [ATL] and 7 HTLV-1-associated myelopathy/tropical spastic paraparesis [HAM/TSP]). All patients with HTLV-1 and−2 were offered to study their relatives. Two out of 37 (5.4%) descendants tested were positive for HTLV-1. Sexual partners were studied; among 6 out of 11 couples (54.5%) were found positive (5 HTLV-1 and 1 HTLV-2). Other relatives, such as mothers (1/2) and siblings (1/6), were positive for HTLV-1. According to the place of birth among HTLV-1 carriers, 58% were born in an endemic area or in countries where HTLV infection is considered endemic while for HTLV-2 carriers, 12.5% were born in an endemic area of Argentina. The proviral load (pVL) was measured in all, patients with HTLV-1 being higher in symptomatic compared with asymptomatic carriers. In addition, two pregnant women were early diagnosed during their puerperium and breastmilk replacement by formula was indicated. Inhibition of lactation was also indicated. Our study provides tools for a multidisciplinary approach to the infection and reinforces the importance of having specialized clinical units in neglected diseases, such as HTLV for counseling, clinical and laboratory follow-up, and providing useful information for patients for self-care and that of their families.
format Online
Article
Text
id pubmed-9307993
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93079932022-07-24 Making Visible HTLV Infection in a Non-endemic Area of Argentina Simioli, Federico R. Bouzas, Maria B. Mijalovsky, Dana Pineda, Maria V. Mammana, Lilia Mangano, Andrea Orduna, Tomas A. Front Med (Lausanne) Medicine In Argentina, the human T-cell lymphotropic virus type 1 (HTLV-1) infection has been documented mainly among blood banks with a prevalence of ~0.02–0.046% for Buenos Aires city, 0.8% for the northeast, and 1% for the northwest; both areas are considered endemic for HTLV-2 and 1, respectively. Policies and specific guidelines for testing blood donors for HTLV are included since 2005. Screening for antibodies is performed at blood banks and confirmatory testing is performed at reference laboratories. There are no specific recommendations for the assistance of communities and individuals affected, nor referral to specialized clinics on the HTLV infection. In 2016, as a strategy of intervention, we opened a specialized clinical attendance in a referral infectious diseases public hospital for the comprehensive approach to patients with HTLV, offering follow-up and counseling for patients and their families for the early diagnosis of HTLV-1/2 and related diseases. During the study, 124 patients with presumptive HTLV positive diagnosis from blood bank, symptomatic patients (SPs), relatives, and descendants visited the unit. A total of 46 patients were HTLV positive (38 HTLV-1 and 8 HTLV-2). There were nine SPs (2 adult T-cell leukemia/lymphoma [ATL] and 7 HTLV-1-associated myelopathy/tropical spastic paraparesis [HAM/TSP]). All patients with HTLV-1 and−2 were offered to study their relatives. Two out of 37 (5.4%) descendants tested were positive for HTLV-1. Sexual partners were studied; among 6 out of 11 couples (54.5%) were found positive (5 HTLV-1 and 1 HTLV-2). Other relatives, such as mothers (1/2) and siblings (1/6), were positive for HTLV-1. According to the place of birth among HTLV-1 carriers, 58% were born in an endemic area or in countries where HTLV infection is considered endemic while for HTLV-2 carriers, 12.5% were born in an endemic area of Argentina. The proviral load (pVL) was measured in all, patients with HTLV-1 being higher in symptomatic compared with asymptomatic carriers. In addition, two pregnant women were early diagnosed during their puerperium and breastmilk replacement by formula was indicated. Inhibition of lactation was also indicated. Our study provides tools for a multidisciplinary approach to the infection and reinforces the importance of having specialized clinical units in neglected diseases, such as HTLV for counseling, clinical and laboratory follow-up, and providing useful information for patients for self-care and that of their families. Frontiers Media S.A. 2022-07-08 /pmc/articles/PMC9307993/ /pubmed/35879924 http://dx.doi.org/10.3389/fmed.2022.892159 Text en Copyright © 2022 Simioli, Bouzas, Mijalovsky, Pineda, Mammana, Mangano and Orduna. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Simioli, Federico R.
Bouzas, Maria B.
Mijalovsky, Dana
Pineda, Maria V.
Mammana, Lilia
Mangano, Andrea
Orduna, Tomas A.
Making Visible HTLV Infection in a Non-endemic Area of Argentina
title Making Visible HTLV Infection in a Non-endemic Area of Argentina
title_full Making Visible HTLV Infection in a Non-endemic Area of Argentina
title_fullStr Making Visible HTLV Infection in a Non-endemic Area of Argentina
title_full_unstemmed Making Visible HTLV Infection in a Non-endemic Area of Argentina
title_short Making Visible HTLV Infection in a Non-endemic Area of Argentina
title_sort making visible htlv infection in a non-endemic area of argentina
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307993/
https://www.ncbi.nlm.nih.gov/pubmed/35879924
http://dx.doi.org/10.3389/fmed.2022.892159
work_keys_str_mv AT simiolifedericor makingvisiblehtlvinfectioninanonendemicareaofargentina
AT bouzasmariab makingvisiblehtlvinfectioninanonendemicareaofargentina
AT mijalovskydana makingvisiblehtlvinfectioninanonendemicareaofargentina
AT pinedamariav makingvisiblehtlvinfectioninanonendemicareaofargentina
AT mammanalilia makingvisiblehtlvinfectioninanonendemicareaofargentina
AT manganoandrea makingvisiblehtlvinfectioninanonendemicareaofargentina
AT ordunatomasa makingvisiblehtlvinfectioninanonendemicareaofargentina